Diabetes drugs offered fresh start (Nature News, 21 July 2010)

UK's NICE rejects Roche's Avastin in breast cancer (Reuters, 8 July 2010)

Roche sticks to 2010 goals despite earnings miss (Reuters, 22 July 2010)

22 Jul 2010

Following a series of disappointments for it's breast cancer drug Avastin (generic name bevacizumab) in both the UK and US this month, Roche resolves to maintain its 2010 outlook.

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read